iX Biopharma in talks for consumer business joint venture with Orion Specialty Labs, GLD Partners

  • IX Biopharma is in advanced talks with Orion Specialty Labs and GLD Partners on a joint venture for its consumer business under a new holding company.
  • Manufacturing equipment will be relocated from Croydon, Australia to Orion’s 503B-licensed Nevada facility, targeted for completion in Q3 2026.
  • Equipment will be loaned to Orion while definitive agreements are finalized; IX retains ownership of the equipment and its intellectual property.
  • Move supports US-based manufacturing needed for a US$40.95 million Defense Department Wafermine contract, including FDA emergency-use authorization requirements.
  • Shift also aims to avoid potential US tariffs of up to 100% on Australian imports, cut lead times, and start production before new JV freeze dryers arrive in March 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IX Biopharma Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: W7VLY5WNYHZE7TJ8) on June 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.